Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in MEDP — Medpace Holdings, Inc.

CIK 1125816 Wheaton, IL
Back to MEDP Full portfolio

Position in MEDP

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$27,056,223
-$4,001,025 QoQ
Shares Held
51,089
-21.0% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#71
of 693 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MEDP Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $1,364,038,790 across 24 Diagnostics & Research names. MEDP ranks #11 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 A
Agilent Technologies, Inc.
 2,079,578 $276,230,345
2 ILMN
Illumina, Inc.
 907,489 $159,563,790
3 NEO
Neogenomics Inc
 10,113,261 $147,552,477
4 VCYT
Veracyte, Inc.
 2,507,902 $147,289,084
5 NTRA
Natera, Inc.
 511,214 $138,769,040
6 IDXX
Idexx Laboratories Inc /De
 202,754 $106,737,815
7 WAT
Waters Corp /De/
 272,470 $102,187,148
8 DGX
Quest Diagnostics Inc
 290,970 $61,671,091

All Filings in MEDP

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,056,223 51,089
2026-03-31 $31,057,248 64,677
2025-12-31 $38,015,280 67,685
2025-09-30 $5,051,107 9,824
2025-06-30 $13,250,855 42,219
2025-03-31 $6,269,910 20,578
2024-12-31 $14,806,162 44,566
2024-09-30 $35,981,971 107,795
2024-06-30 $44,754,092 108,666
2024-03-31 $51,622,483 127,731
2023-12-31 $49,032,538 159,960
2023-09-30 $40,459,923 167,100
2023-06-30 $7,365,053 30,666
2023-03-31 $9,514,201 50,594
2022-12-31 $9,862,621 46,432
2022-09-30 $5,228,102 33,264
2022-06-30 $524,443 3,504
2022-03-31 $4,780,754 29,224
2021-12-31 $22,722,486 104,404
2021-09-30 $25,478,790 134,609
2021-03-31 $21,316,164 129,937
2020-12-31 $13,208,827 94,891
2020-09-30 $10,060,629 90,028
2020-06-30 $9,611,198 103,324
2020-03-31 $8,388,874 114,321